NIPER Hajipur and IPC Sign Pharmaceutical Standards MoU

NIPER Hajipur signed MoU with Indian Pharmacopoeia Commission to strengthen pharmaceutical standards and patient safety.
Collaboration focuses on joint research in impurity profiling, analytical methods, and quality control protocols development.
Partnership includes developing reference standards for biologics, biosimilars, and cell/gene therapies for Indian Pharmacopoeia.
MoU envisions capacity building initiatives in biosimilars, cell/gene therapy, and blood-related products.